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The molecular basis for bacterial responses to host
signals during natural infections is poorly under-
stood. The gram-positive bacterial pathogen group A
Streptococcus (GAS) causes human mucosal, skin,
and life-threatening systemic infections. During the
transition from a throat or skin infection to an inva-
sive infection, GAS must adapt to changing environ-
ments and host factors. To better understand how
GAS adapts, we used transcript profiling and func-
tional analysis to investigate the transcriptome of a
wild-type serotype M1 GAS strain in human blood.
Global changes in GAS gene expression occur rapidly
in response to human blood exposure. Increased
transcription was observed for many genes that likely
enhance bacterial survival, including those encoding
superantigens and host-evasion proteins regulated by
a multiple gene activator called Mga. GAS also coordi-
nately expressed genes involved in proteolysis, trans-
port, and catabolism of oligopeptides to obtain amino
acids in this protein-rich host environment. Compar-
ison of the transcriptome of the wild-type strain to
that of an isogenic deletion mutant (covR) mutated
in the two-component regulatory system designated
CovR-CovS reinforced the hypothesis that CovR-CovS
has an important role linking key biosynthetic, cata-
bolic, and virulence functions during transcriptome
restructuring. Taken together, the data provide cru-
cial insights into strategies used by pathogenic bacte-
ria for thwarting host defenses and surviving in hu-
man blood. (Am J Pathol 2005, 166:455–465)
Little is known about how pathogenic bacteria adapt to
permit growth in human blood. A model organism to ad-
dress this issue is group A Streptococcus (GAS), which
causes a broad spectrum of human diseases ranging from
relatively mild throat and skin infections to fulminant, life-
threatening invasive diseases such as puerperal sepsis,
myositis, necrotizing fasciitis, and streptococcal toxic shock
syndrome.1–3 GAS has long been known to be capable of
replicating in nonopsonizing human blood.2 However, de-
spite years of study, the molecular mechanisms mediating
GAS-host interactions remain poorly understood. Several
bacterially encoded molecules contribute to GAS immune
evasion by interfering with opsonophagocytosis and killing
by polymorphonuclear lymphocytes.2,3 Others protect GAS
by disrupting important innate host defenses such as com-
plement activation and complement-mediated cell lysis.2,3
However, additional bacterial proteins likely are involved.
Recently, Gryllos and colleagues4 demonstrated that the
expression of the hyaluronic acid capsule biosynthesis
(has) operon is stimulated in the bloodstream of infected
mice. In addition, two transcriptome studies have demon-
strated GAS adaptive transcription after in vitro exposure to
human polymorphonuclear lymphocytes and iron limita-
tion.5,6 However, no studies have assessed GAS global
transcription or the regulatory networks that govern GAS
adaptive responses during growth in human blood.
A two-component regulatory system (TCS) designated
CovR-CovS (Cov, control of virulence; also known as
CsrR-CsrS) plays an important role in GAS virulence by
negatively regulating the has operon and other genes
encoding secreted and membrane-anchored factors that
promote survival and virulence in humans.7–10 Isogenic
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cov mutant strains are hypervirulent in mouse skin in-
fections and have enhanced resistance in vitro to com-
plement-mediated opsonophagocytic killing by human
polymorphonuclear lymphocytes,7–9,11 consistent with in-
creased virulence gene transcription and extracellular
capsule production. Frameshift mutations in the covRS
locus also arise spontaneously in vivo, and synergistically
enhance the virulence of wild-type (WT) bacteria,12 and
hyperencapsulated GAS variants have been isolated af-
ter in vitro passage in human blood.13 Taken together,
these observations suggest that the CovR-CovS TCS re-
sponds to molecular signals in human blood.
We directly analyzed GAS global transcription during
ex vivo culture in human whole blood using a high-density
oligonucleotide array. We hypothesized that the CovR-
CovS TCS is involved in GAS adaptation allowing growth
in blood and that virulence gene expression would be
augmented. To test this hypothesis, we compared the
transcriptomes of a WT, serotype M1 GAS strain and its
isogenic covR-deletion mutant (covR). The data provide
important new insights into the early stages of GAS sur-
vival in blood and evidence that the CovR-CovS TCS
functions to coordinate bacterial fitness attributes during
disseminated host infections.
Materials and Methods
Bacterial Strains and Growth Conditions
Serotype M1 strain MGAS5005 and the isogenic
MGAS5005 covR derivative (JRS950) have been de-
scribed.9 GAS was cultured on Trypticase soy agar con-
taining 5% sheep blood agar (Becton Dickinson, Cock-
eysville, MD), or in Todd-Hewitt (TH) broth (Becton
Dickinson) containing 0.2% (w/v) yeast extract (THY;
Difco Laboratories, Detroit, MI), at 37°C in 5% CO2. Bac-
teria were grown in THY broth to late-exponential phase
(OD600  0.8), harvested by centrifugation at 6000  g at
37°C for 8 minutes, suspended in an equal volume of
human whole blood maintained at 37°C with 5% CO2,
and then incubated. Aliquots were removed at 0, 30, 60,
and 90 minutes, and added to 2 vol of RNAProtect bac-
teria reagent (Qiagen, Valencia, CA). Cells were har-
vested by centrifugation and stored at 80°C before
bacterial RNA isolation. Viable counts were obtained for
GAS cultures immediately before time course initiation
and after 4-hour co-culture in human blood.
Human Study Participants and Whole Blood
Collection
Owing to inherent interindividual and gender-related vari-
ability of human peripheral blood specimens, 12 human
blood donors were used to provide generalizability and
sufficient statistical power. Clinical data measurements
showed subject and gender-associated variability, so
that six donor patients of each gender were used. All
blood donors were within normal parameters for 24
tested analytes (data not shown). Heparinized human
venous blood (125-ml) was collected from the 12 healthy
individuals in accordance with a protocol approved by
the Institutional Review Board for Human Subjects, Na-
tional Institute of Allergy and Infectious Diseases. In-
formed consent was obtained from all study participants.
GAS clinical disease history was not assessed. Blood
donors (six females, six males) were from many ethnic
backgrounds and their ages ranged from 26 to 54 years;
(mean age: females, 37.2 years; males, 36.2 years). Hep-
arin was used in preference to ethylenediaminetetraace-
tic acid as an anti-coagulant because ethylenediami-
netetraacetic acid chelates divalent cations, which would
influence cellular functions during GAS-blood cell inter-
actions. On collection, venous blood was divided into
aliquots for antibody (Ab) testing (1 ml), cytokine analysis
(1 ml), and blood analysis (1 ml; Alpha Veterinary Labo-
ratories, Hamilton, MT). The remaining blood was main-
tained at 37°C with 5% CO2 until the time course was
initiated.
RNA Isolation
Bacterial cell pellets were suspended in 5 vol of EL buffer
(Qiagen), incubated for 20 minutes on ice, and separated
from lysed erythrocytes by centrifugation at 4500  g at
4°C for 6 minutes. Cells were rinsed with 2 vol of EL
buffer. RNA was isolated from the bacterial pellets as
described,9 except that 0.8 g of bacteriophage MS2
carrier RNA (Roche Bioscience, Indianapolis, IN) and
250 g of glycogen (Roche) were added. RNA was pu-
rified further using the RNeasy 96 kit (Qiagen), with on-
column RNase-free DNase I treatment and after treat-
ment with DNAFree (Ambion, Austin, TX). Electrophoretic
analysis with an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies Inc., Palo Alto, CA) and A260/A280 ratios were
used to assess RNA integrity. TaqMan polymerase chain
reaction (PCR) assays were performed with RNA tem-
plates to ensure contaminating genomic DNA was absent
as described.9
cDNA Labeling
RML GeneChip targets were prepared according to the
protocol supplied by the manufacturer (Affymetrix Inc.,
Santa Clara, CA), with modifications. Control spike tran-
script mixes (containing 0.025 to 0.000025 pmol each of
DAP, LYS, THR, and TRP spike transcript cRNAs) (1 l)
were added to each RNA aliquot, and 4.5 g of random
primers (Invitrogen, Carlsbad, CA) were annealed (10
minutes at 70°C, 10 minutes at 25°C). First-strand cDNA
was synthesized with 25 U/l SuperScript III (Invitrogen)
in the presence of 0.5 mmol/L dNTPs, 0.5 U/l SUPERa-
seIn RNase inhibitor (Ambion), and 10 mmol/L dithiothre-
itol (10 minutes at 25°C, 60 minutes at 37°C, 60 minutes
at 42°C, 10 minutes at 70°C). RNA was removed by
hydrolysis in 1 N NaOH (30 minutes at 65°C), and neu-
tralized with 1 N HCl before cDNA purification using the
QIAquick 96 kit (Qiagen) according to the manufacturer’s
recommendations, except that an extra 10-minute cen-
trifugation was used to remove trace phycoerythrin-eth-
anol buffer. For cDNA fragmentation, 10.5 g of cDNA
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and 1.75 U (0.35U/g) of DNase I (Roche) were used (10
minutes at 37°C, 10 minutes at 98°C). The fragmented
cDNA (averaging 50 to 100 bases) was 3 end-labeled
with biotin-ddUTP using the BioArray terminal labeling kit
(Enzo Life Sciences, Inc., Farmingdale, NY) (60 minutes
at 37°C) according to the manufacturer’s instructions.
The fragmented and end-labeled cDNA was added to the
hybridization solution without further purification.
RML GeneChip Composition and Performance
An anti-sense oligonucleotide array (18-m feature size)
representing 249,690 25-mer probe pairs (16 pairs per
probe set) was manufactured by Affymetrix Inc.14 The
custom GeneChip (RMLChip herein) contains 2636
probe sets (42,351 probe pairs) for 2636 predicted GAS
open reading frames (ORFs). These features represent a
composite superset of six GAS genomic sequences rep-
resentative of serotypes M1, M3, M5, M12, M18, and M49
(sequenced strains are designated SF370, MGAS315,
Manfredo, MGAS9429, MGAS8232, and CS101, respec-
tively). To facilitate the analysis of GAS samples in the
presence of host cells, all probe set sequences were
pruned during the design process to exclude cross-hy-
bridizing sequences (those exhibiting sequence similar-
ity) with human, rat, and mouse genome ORFs repre-
sented on Affymetrix Inc. arrays, and 12 additional
bacterial genome sequences. Although the RMLChip
was not designed based on the genome sequence of
strain MGAS5005, the genome sequence has since been
obtained and annotated for this strain under GenBank
accession no. CP000017 (Sumby PA, Madrigal A, Kent
KD, Porcella SF, Ricklefs SM, Virtaneva K, Sturdevant D,
Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM, sub-
mitted), and the composite RMLChip contains 1692 re-
dundant probe sets (high BLAST score match to
MGAS5005) that represent more than 90% coverage of
the total number of predicted coding regions (1869
ORFs) encoded by this M1 GAS genome.
GeneChip Hybridization
Target hybridizations, washing, staining, and scanning
were performed by the National Institute of Allergy and
Infectious Diseases Affymetrix core facility (Science
Applications International Corporation (SAIC) Frederick,
MD), following the manufacturer’s recommendations
(Affymetrix).
Experimental Design and Statistical Analysis
For each of the 12 human blood donors, arrays were
hybridized in a complete two-factor experimental design
with two treatment levels (WT or mutant GAS strain) and
four time points (0, 30, 60, and 90 minutes). To minimize
experimental variability, all 12 blood samples were col-
lected within a 2-hour time period and GAS culturing was
conducted in parallel. Cultured samples were random-
ized before all preparation procedures were performed.
Expression estimates for each gene were obtained
using the PM-MM difference model of dCHIP version 1.3
software available at http://www.dchip.org/.15 The gene
expression estimates were further normalized across
samples by simple quadratic scaling on all genes with
the median expression for each gene as a baseline.16
Two-dimensional scatterplots were generated for all pairs
of samples within a factor level to examine the uniformity
of the normalized expression values across donors; five
samples with low correlation to the other within-factor
samples were removed as outliers (data not shown).
Principal component analyses were performed using all
MGAS5005 genome-specific probe sets (n  1925). Hi-
erarchical clustering also was performed to explore sin-
gle gene effects.
A mixed-effects analysis of variance model was applied
to an absolute square root transform of the dCHIP expres-
sion estimates, with time, treatment, and gender as fixed
effects, and subject as a random effect using Partek Pro 5.1
(Partek Inc., St. Louis, MO). In reporting the significance of
effects, both the nominal P values and the false discovery
rate (FDR) Q-value17 were reported (Supplementary Table
1; supplementary data available at http://ajp.amjpathol.org)
because it is important to account for multiple testing. The
experimental design permitted differentially expressed
genes to be identified with very high confidence, corre-
sponding to FDRs of 0.06% for time, strain, and subject
effects. FDR levels of 0.06% are equivalent to 1 false
positive in a genome encoding 1900 ORFs (approxi-
mately the size of the GAS genome).
To elucidate the biology underlying the GAS transcrip-
tional response, we looked for evidence that sets of genes
belonging to a functional category showed a coordinated
response to experimental factors. Functional annotation for
the MGAS5005 genome was generated through in-house
compilation. All probe sets were assigned to 1 of 17 func-
tional categories (including unknown), and further classified
into 1 of 52 subcategories. The differential expression of a
functional category was assessed across both time and
treatment by an approach first used in Virtaneva and col-
leagues,18 that is similar to recent efforts, such as Mootha
and colleagues19 For each gene, F-statistics were obtained
for the time and treatment effects from a fixed-effects anal-
ysis of variance model. A two-sample Wilcoxon ranked sum
statistic was then computed for the rank statistics of genes
belonging to the functional category relative to the ranks of
all remaining genes. Empirical P values for each functional
category were obtained by recomputing Wilcoxon statistics
across 10,000 permutations of the array assignments. In
each permutation, the subject assignment of each array
was held constant, whereas the treatment and time assign-
ments were randomized. This approach allowed computa-
tion of permutation-based estimates for the FDR20 to ac-
count for the multiple testing of functional categories.
Nominal P values and FDR estimates are reported for the
set of 17 categories and 52 subcategories (Supplementary
Table 2).
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Reverse Transcriptase (RT)-PCR
Real-time PCR assays were conducted to confirm a subset
of the microarray data as described,6 except that Platinum
Quantitative PCR SuperMix (Invitrogen) was used and each
PCR reaction was performed in quadruplicate.
Flow Cytometry
Strains MGAS5005 and JRS950 were grown in vitro in
THY broth to late-exponential phase. Bacteria were col-
lected by centrifugation, rinsed once with Dulbecco’s
phosphate-buffered saline (PBS) (Sigma-Aldrich, St.
Louis, MO), suspended in Dulbecco’s PBS in 96-well
plates, and maintained at 4°C throughout the staining
procedure. Cells were blocked with 2% human serum in
Dulbecco’s PBS (staining buffer, SB) for 10 minutes be-
fore immunostaining for 30 minutes with GAS-specific,
affinity-purified primary Abs (Bethyl Laboratories, Mont-
gomery, TX) in SB.21 GAS antigens that were more highly
expressed at the RNA level in the covR mutant strain
were selected for the analysis. Control Abs were raised in
rabbits against rSLA (spyM31204), an ORF that is not
encoded in the GAS serotype M1 MGAS5005 genome.
Detection was achieved using phycoerythrin-conjugated
polyclonal donkey anti-rabbit IgG (1:500; Jackson Immu-
noResearch Laboratories, Inc., West Grove, PA) in SB for
30 minutes, and subsequent flow cytometric analysis
performed with a FACscalibur flow cytometer (Becton
Dickinson, Mountain View, CA).21
Results
GAS Molecular Signature during Growth in
Human Blood
To model bacteria proliferating rapidly during host sep-
sis, GAS cells in the late-exponential phase of growth
were recultured at approximately the same cell density in
freshly heparinized human whole blood for 0 to 90 min-
utes, and their transcribed cDNAs used to prepare mi-
croarray hybridization targets. Evaluation of scatterplots,
spike-in control transcripts (data not shown), and histo-
grams of the ex vivo expression data (Supplementary
Figure 1) indicated high quality for the resultant data set
(comprised of 91 RMLChips). The resultant principal
component analyses plots and clustering dendrogram
discriminated by treatment within time (Supplementary
Figure 2).
The expression data revealed that extensive remodel-
ing of the transcript profile occurred in both strains during
ex vivo blood culture. Within 30 minutes, 716 transcripts
were more abundant (up-regulated) and 425 transcripts
were less abundant (down-regulated) in the WT strain
(Supplementary Table 1). Time affected transcription of
the greatest number of GAS genes (n  1467, or 76.2%
of the genome) belonging to functional categories ex-
pected to be important for growth adaptation in blood,
such as de novo synthesis of macromolecular precursors
(including co-factors and nucleotides), carbohydrate me-
tabolism, membrane transport, and transcriptional regu-
lation (Supplementary Figure 3A and Supplementary Ta-
ble 1). To investigate the ex vivo expression data in more
detail, we identified functional categories that were over-
represented within the differentially expressed GAS
genes and again, temporal effects were most significant.
Transcription of 41 genes involved in co-factor biosyn-
thesis (particularly, chorismate and folate) was signifi-
cantly reduced with time (nominal P value  0.0005; FDR
estimate  0.0028) (Figure 1A and Supplementary Table
2). Reduced transcription of genes functioning in cell enve-
lope biogenesis, including biosynthesis of peptidoglycan
(n  47), and of membrane lipids (n  31; nominal P 
0.005; FDR 0.10) (Figure 1B and Supplementary Table 2),
also occurred in both strains throughout time in whole
blood. Significant expression changes (nominal P  0.05;
FDR  0.10) also were observed throughout time in cellular
Figure 1. Statistical analysis of GAS functional categories for time effects
during ex vivo blood culture. A and B: Plots show the cumulative distribution
for ranked F statistics of genes within the selected functional categories when
testing for the effect of time in blood (hatched lines). If the degree of
differential expression of genes within a category is the same as that of all
other GAS genes, the distribution will trace the identity line (black diagonal
line). If small P values occur with greater frequency among genes in a
category, then the distribution curve diverges from the diagonal line, with
the most differentially regulated genes shifted to the right. Tick marks at
the top of plots show the ranks of genes within the functional category,
indicated by their assigned gene name or spy ORF numbers. All genes
exhibiting significant differential expression at the nominal 0.05 level (F
2.71) are shaded in the plot, demonstrating the extensive transcriptional
changes observed throughout time. The effect of time on GAS shows signif-
icant differential expression in co-factors (A, nominal P  0.0005; FDR
0.005) and membrane lipids (B, nominal P  0.005; FDR 0.10), during
blood culture.
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shape and division, carbohydrate metabolism, and nucleo-
tide metabolism. Additional noteworthy functional catego-
ries in our time analysis showing respectable FDR estimates
when controlling for multiple testing include heat shock
proteins (nominal P  0.05; FDR  0.14), amino acid ca-
tabolism (nominal P  0.05; FDR  0.14), and stress ad-
aptation (nominal P  0.087; FDR  0.16) (Supplementary
Table 2).
Adaptive Metabolic Shift in WT GAS during
Whole Blood Exposure
Human blood is relatively poor in free amino acids (AAs),
but rich in carbon and energy sources such as carbohy-
drates and peptides.22 Within 30 minutes of blood cultur-
ing in the WT strain, transcript levels of genes involved in
glycolysis were reduced, suggesting a depletion of bac-
terial intracellular glucose levels. We also observed mas-
sive transcriptional changes that reflect temporal adjust-
ment of GAS cellular metabolism, firstly to augment
transport and fermentation of alternate metabolizable
carbohydrates, and subsequently to transport and catab-
olize oligopeptides, aminosugars, and AAs (Supplemen-
tary Table 1). In light of the temporal derepression ob-
served in the WT during blood culture of GAS transcripts
encoding nutrient-releasing proteins, including the potent
cytolysin streptolysin S (SLS: sagA), streptokinase (ska),
and the Ig-endopeptidase designated Mac (spy0861),
carbon- and nitrogen-containing host substrates would
be expected to become increasingly available through-
out time for bacterial use. Consistent with this idea, in-
creased transcription after 30 minutes of oligopeptidase
F (pepF), oligopeptidase (pepB), and the oligopeptide
permease (opp) operon suggested a concerted strategy
to acquire oligopeptides. Temporal reduction of tran-
scripts encoding RelA (spy1981), encoding the bifunc-
tional enzyme involved in the synthesis and hydrolysis of
(p)ppGpp during amino acid starvation, and CodY
(spy1777), encoding a pleiotropic transcriptional repres-
sor responsive to branched chain AAs, supports the no-
tion that GAS intracellular AA levels likely accumulated in
the WT strain within 30 minutes in human blood (Supple-
mentary Table 1). Temporal reduction of transcripts en-
coding the transcriptional regulator Rgg, which re-
presses arginine and serine degrading enzymes when
glucose is present,23 coincided with temporal up-regula-
tion of transcripts encoding arginine (arcCBA: spy1543-
44, and 1547) and serine (sdhBA: spy2189-90) catabolic
enzymes, contributing to a metabolic transition from car-
bohydrate to AA fermentation.
GAS Virulence Gene Transcription during Blood
Adaptation
On blood exposure, we observed accumulation of tran-
scripts belonging to the multigene activator (mga) regu-
lon in both GAS strains.24,25 Maximum levels of mga
(spy2019) regulator transcripts were detected 30 minutes
after blood exposure (Supplementary Table 1). In con-
cordance, Mga-regulated transcripts emm1 and sic, en-
coding the surface-associated Emm1 (or M1) protein and
secreted streptococcal inhibitor of complement (SIC),
subsequently accumulated (Supplementary Table 1).
These virulence determinants promote bacterial adher-
ence and subversion of Fc- and complement-mediated
immune defenses.2,3 Similar patterns of increased tran-
scription were observed for other genes located up-
stream of mga indicating possible co-regulation, includ-
ing those encoding a putative metal-transporting ABC-
transporter TptA-D (spy2033-39), a TCS designated Irr-
Ihk (spy2027-26), and secreted antigens Isp (spy2025)
and SPy2023. After blood exposure, levels for transcripts
encoding Mga-independent virulence determinants such
as capsular polysaccharide (hasABC; spy2000-02),
streptolysin S (sagA; spy0738) and accessory genes, and
Ig-endopeptidase Mac (spy0861) also increased in both
strains. In contrast, the levels of transcripts encoding the
cysteine protease (speB; spy2039) and transcriptional
repressor cathelicidin-resistance gene regulator (crgR;
spy1870) were temporally reduced in both strains during
blood culture.26 However, reduction of speB and crgR
transcripts is predicted to (indirectly) enhance bacterial
resistance to phagocytosis and host antimicrobial pep-
tides, respectively.
Transcripts encoding ribosomal protein subunits, mo-
lecular chaperones GroEL, DnaJ, and DnaK and transla-
tion elongation factor Tu (TufA), as well as others involved
in glycolysis (such as Fba and Eno) or anaerobic respi-
ration (Ldh) were among the most abundant GAS tran-
scripts detected in the WT strain (Supplementary Figure 4
and Supplementary Table 3), thereby supporting recent
theoretical predictions for highly expressed GAS
genes.27 Interestingly, transcripts encoding a transcrip-
tional regulator (RofA: spy0124) and several proven viru-
lence factors (Emm1, SIC, SLO, and ScpA) also were
among the most abundant GAS transcripts; the latter
remained highly abundant throughout the time course of
the experiment.
Importantly, we also observed an immediate and
robust increase of transcript levels for the pyrogenic
toxin superantigen (PTSAg)-encoding genes speA
(spyM180393) and speJ (spy0436) in both GAS strains
throughout time in blood (Supplementary Table 1). More
modest increases of speG (spy0212) and smeZ
(spy1998) transcript levels occurred. Increased levels of
PTSAg transcripts were verified by real-time RT-PCR
analysis (Supplementary Figure 5). Overstimulation of
proinflammatory host responses will disturb innate host
defenses, increase host cell damage, and concomitantly
release carbon and energy sources for bacterial use.
Temporal Expression of Hypothetical Genes in
Blood
Forty-three percent of the genes in strain MGAS5005 are
hypothetical ORFs of unknown function. Although many
of these genes have homologues in other bacteria, little
or no functional information is known in these other sys-
tems. Blood exposure significantly affected the level of
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531 GAS transcripts encoding proteins of unknown func-
tion. Of the 531 affected genes, 40 genes have been
identified as essential for growth in Bacillus subtilis28 and
27 in Staphylococcus aureus.29,30 Transcripts encoding a
basic, hydrophilic, GAS surface antigen (SPy0843) in-
creased approximately twofold within 30 minutes of blood
exposure, and then gradually declined. SPy0843 is ho-
mologous to BspA of Bacteroides forsythus, and is known
to be made during GAS infections.31
CovR-CovS Regulatory Influence on GAS Gene
Transcription in Blood
Transcription of the covRS operon, which is negatively
autoregulated, and of the covRS activator gene rocA
(spy1605),32 increased within 30 minutes after transfer of
the WT strain from THY culture broth into whole blood
(Supplementary Table 1). covRS transcripts returned to
pre-existing levels by 60 minutes, whereas rocA levels
remained elevated throughout the time course. After de-
repression of covRS at 30 minutes, derepression oc-
curred thereafter of many known virulence-associated
genes and other genes under CovR-regulation, such as
sagA (spy0738), mac (spy0861), isp2 (spy1801), and ska
(spy1979), to name a few (Supplementary Table 1).9
Strain genotype (covR versus WT) affected a large
proportion of GAS transcripts (n  1075 genes, or 55.8%
of the genome) (Supplementary Figure 3B). Transcripts
involved in protein folding and/or modification (nominal
P  0.005; FDR  0.028) (Supplementary Figure 6a),
amino acid metabolism (nominal P  0.05; FDR  0.14)
(Figure 2A), and amino acid catabolism (nominal P 
0.05; FDR  0.49) were consistently more abundant in
the covR mutant in our functional analysis (Supplemen-
tary Table 2). We also observed up-regulation of 36 GAS
transcripts involved in proven or putative virulence inter-
actions in the covR mutant strain compared to WT (Fig-
ure 2B), including cfa (spy1273) encoding the CAMP
factor hemolysin, and sceD (spy2191). Derepression of
the capsule biosynthesis operon (has; spy2200-02) in the
covR strain was observed and verified by RT-PCR anal-
ysis (Supplementary Figure 4). In addition, the cathelici-
din resistance transcriptional repressor crgR (spy1870)26
transcripts were more abundant in the covR strain (Q 
0.0003). The category “virulence-interacting” did not
achieve statistical significance after multiplicity correc-
tion in our strain comparison (Supplementary Table 2),
primarily owing to the presence of numerous covR-inde-
pendent virulence-associated transcripts, such as the
mga-regulated emm1 and isp (spy2025), and others.
However, derepression of 18 of 52 virulence-associated
transcripts (Q 0.0006) concurs with in vitro data previ-
ously reported for cov strains,9,33 and emphasizes the
impact of this regulatory locus.
Transcripts of the following genes were down-regu-
lated in the covR mutant relative to the WT strain:
spy0425-0427 and spy2105-10 encoding purine nucleo-
side biosynthesis genes; spy1785-1798 encoding the
heme-binding iron transporter system Shp (shp/siaA;
spy1796) and (htsABC/sia; spy1795-93); and dppA-E
(spy2000-04) encoding the dipeptide permease trans-
porter, as seen previously in vitro.9 Transcription of the
genes encoding stringent factor RelA (spy1981) and
some AA-tRNA synthetases also was reduced in the
covR strain relative to the WT strain (Supplementary
Table 1). The effect of time on oxidative stress, a func-
tional category that was not statistically overrepresented
in the expression data (P value  0.600), is depicted for
illustrative purposes (Supplementary Figure 6b).
The CovR-CovS TCS plays an important role in modu-
lating GAS virulence capacity.9,34 Our transcriptome
analysis supports the hypothesis that CovR-CovS medi-
ates GAS compensatory metabolism in blood. For exam-
ple, transcripts encoding the pleiotropic regulator carbon
catabolite control protein (CcpA; spy0514),35 were higher in
the covR mutant than in the WT strain throughout the time
course (Q  0.0001). Transcripts of genes encoding pro-
teins involved in transport of cations (spy1240-1249) and
carbohydrates (spy1591-95), as well as folate (spy1096-
1100) and chorismate (spy1350-1358) biosynthesis also
Figure 2. Statistical analysis of GAS functional categories for treatment ef-
fects during ex vivo blood culture. A and B: Plots show the cumulative
distributions for ranked test statistics of genes within the selected functional
categories for treatment effects in blood (hatched lines). Genes differen-
tially expressed with treatment that exhibit a leftward shift indicate up-
regulation in the covR strain and those showing a rightward shift indicate
down-regulation. All genes exhibiting significant differential expression at
the nominal 0.05 level ( t  1.99) are shaded in the plot. The effect of
treatment in blood on GAS amino acid metabolism (A) showing up-regula-
tion in the covR strain (nominal P value 0.05; FDR  0.14), and virulence
interacting (B), showing up-regulation in the covR strain, but not in a
statistically significant manner (nominal P value  0.11; FDR  0.69).
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were higher in the covR mutant (Supplementary Table 1).
Strain-dependent patterns also were seen for transcripts
encoding arginine catabolic enzymes (ArcCBA: spy1543-
44-47), serine dehydratase (sdhBA; spy2189-90), putative
phosphotransferase systems (PTS) for galactitol (spy1709-
12) and N-acetylglucosamine (spy629-34), carbohydrate
assimilatory functions (GlpFOK: spy1682-4; spy1586;
spy1704-12), and those putatively involved in aminosugar
metabolism (spy0716; spy1399; spy1694). These strain-
dependent transcript differences indicate that CovR-CovS
is involved in substantial restructuring of GAS metabolism in
whole blood.
Validation of Oligonucleotide-Array Gene
Expression Results
We used real-time RT-PCR to validate the microarray data.
A subset of five targets was selected to encompass a range
of expression estimates from within the RMLChip data set.
Relative expression estimates initially determined with RM-
LChip hybridization also were correlated (slope, m 
1.0044) with RT-PCR results in both strains for all five tested
virulence genes (hasA, speA, speG, speJ, and smeZ) (Sup-
plementary Figure 5; R2  0.755 for all time points; range,
0.72 to 0.88). As others have observed,9,36 we obtained
positive regression slopes indicating that higher relative
transcript estimates were obtained by real-time RT-PCR
determination than by microarray hybridizations.
Confirmation of GAS Surface Antigen
Expression by Flow Cytometry
We used flow cytometry to corroborate the microarray
gene expression data at the protein level. The tested
surface antigens were detected at higher levels on the
hyperencapsulated covR mutant relative to the WT (Ta-
ble 1), a result concordant with the increased transcript
levels in the covR strain detected by RNA profiling at
time 0 for the in vitro grown WT and covR strains (Sup-
plementary Table 1). After a conservative (Bonferroni)
correction for multiplicity testing (P  0.005), four GAS
differentially expressed proteins (Spy0319, OppA, SceD,
and MtsA) were detected with significance (P  0.0001,
0.0006, 0.0007, and 0.004, respectively) on the GAS
strains (Table 1), which is consistent with RMLChip ex-
pression estimates (Supplementary Table 1). Three of the
four antigens are substrate-binding, ABC-type trans-
porter lipoproteins involved in membrane transport,37,38
whereas the function of the secreted SceD protein is
unknown.
Discussion
Adaptive gene expression determines whether bacteria
successfully persist and disseminate during encounters
with host defenses and diverse microenvironments. Iden-
tification of GAS genes uniquely expressed in blood is
important both for understanding infection processes
and for the development of new approaches to control
GAS infections. Unfortunately, there is no current exper-
imental approach that accurately recapitulates the hu-
man blood environment, and inclusion of all host vari-
ables influencing bacterial transcription is presently
unachievable. For example, a patient’s genetic makeup,
innate defenses, cytokine levels, and changing clinical
conditions (such as dehydration, fever, changing electro-
lyte or blood sugar levels, and anemia) likely influence
bacterial responses and infection course. As a first step
toward understanding this complex host-bacterium inter-
action, we aimed to identify GAS transcripts that correlate
with ex vivo exposure to human blood supplied from a
diverse set of donors. To allow for bacterial losses during
isolation from host cells, GAS was inoculated into whole
blood at 108 CFU/ml (or 10 CFU per white blood cell).
Although in vitro phagocytosis assays and experimental
septicemia in animal models are routinely conducted in
this GAS cell density range, lower cell densities are ob-
served during natural human infections. Human whole
blood was used without previous heat treatment (to de-
nature host complement components), thereby enabling
us to measure GAS transcript expression during full in-
teraction of host cellular and bacterial factors. Although
an alternative model species (eg, inbred animal) blood
could have been used, it would have been difficult to
Table 1. Flow Cytometric Analysis of Group A Streptococcus Surface Proteins
Designation Protein Description Mutant WT P value
SPy0319 Surface lipoprotein 22.43 	 0.60 15.00 	 0.68 0.0001
SPyM180281 OppA Surface lipoprotein 23.31 	 1.05 15.03 	 0.98 0.0006
SPy2191 SceD Secreted protein 22.90 	 0.70 18.20 	 0.50 0.0007
SPy0453 MtsA Surface lipoprotein 12.74 	 0.80 9.60 	 0.45 0.0040
SPy1592 Surface lipoprotein 69.87 	 5.08 50.02 	 4.20 0.0064
SPy1245 PstS Surface lipoprotein 25.70 	 0.95 19.73 	 1.97 0.0090
SPyM31204 SLA Secreted protein 13.75 	 0.78 10.58 	 0.95 0.0111
Auto-fluorescence FACs control 4.14 	 0.05 4.29 	 0.04 0.0127
SPy0252 Surface lipoprotein 10.78 	 0.82 8.93 	 0.43 0.0258
Secondary Ab FACs control 4.07 	 0.08 4.15 	 0.12 0.3414
MGAS5005 (WT) and JRS950 (covR) cells were harvested at OD600  0.8 after in vitro growth in THY broth at 37°C with 5% CO2. Immunostaining
was performed with affinity-purified rabbit polyclonal antibodies, or control rabbit -SLA antibodies. GAS surface antigens were detected with a
phycoerythrin-conjugated donkey anti-rabbit IgG secondary antibody, and analyzed by flow cytometry.
Listed are mean fluorescence within the analysis gate 	 SD from two independent experiments comprised of triplicate measurements. Minimums of
17,900 gated events (representing GAS cells) were analyzed for each replicate. Statistical significance was assessed at the P  0.05 level after
Bonferroni correction for 10 comparisons (adjusted P  0.005).
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obtain appropriate volumes of blood, and may have in-
troduced bias owing to species-specific differences in
responding cell types, hemodynamic properties, PTSAg
susceptibilities, proinflammatory cytokine responses,
and host defense mechanisms that likely impact on bac-
terial responses. Moreover, GAS is a human-specific
pathogen, which clearly also justifies the use of human
blood. Randomly selected human blood donations were
preferable because this allowed us to account for indi-
vidual and gender-based variation. Knowing that GAS
must evade innate host defenses in nutrient-depleted
host environments, late exponential phase GAS cells
were chosen for our experimental design because this is
considered a transitional growth phase when bacterial
cell densities are high and nutrient sources (such as
carbon, nitrogen, and the like) become limiting.
Our goal was to comprehensively investigate the GAS
transcriptional response to human blood (as culture me-
dium) and to evaluate the involvement of the CovR-CovS
TCS during blood adaptation. Although the ex vivo growth
technique used in this study successfully mimics some of
the conditions existing within infected hosts, we must
acknowledge it cannot accurately replicate the highly
complex environment that pathogens encounter during
natural infections. Consequently, the salient points of this
ex vivo study are provided within this context. This being
said, our strategy is more clinically relevant than the
analyses of transcriptomes derived from bacteria cul-
tured exclusively in laboratory media, which are artificially
nutrient-rich and lack host factors and cells. Moreover,
the study demonstrated strong evidence for consistent
bacterial adaptive responses to blood components. For
example, on blood exposure we observed increased ex-
pression of GAS genes that interact with host cell sur-
faces (adhesins such as M1, collagen-binding proteins
SclB and Cbp, and capsule),39 and that contribute to the
evasion of host innate defenses (SIC, Mac, and SPEA).
Increased transcription of has genes (encoding capsule)
concurs with data previously obtained for GAS in mouse
blood after intraperitoneal inoculation.4 Human serologi-
cal data have shown that the proteins encoded by many
transcripts we observed were up-regulated during ex vivo
blood culture, such as sic, emm1, ska, and speA, are also
expressed in vivo during disseminated GAS infections.40–42
Our analysis revealed that many genes involved in key
metabolic functions were substantially affected by blood
exposure. Being auxotrophic for most amino acids, GAS
must rely on host sources for anabolic and catabolic
substrates.43 In human blood, which is low in free amino
acids, our data support that GAS coordinates the prote-
olysis, transport, and catabolism of oligopeptides to ob-
tain essential free AAs. Recent discoveries that the pleio-
tropic transcriptional repressor CodY senses intracellular
levels of branched-chain AAs in Bacillus subtilis44 suggest
that CodY (Spy1777) may be involved in mediating some
of the GAS dynamic responses. Importantly, we discov-
ered that the CovR-CovS TCS also plays an important
role during the remodeling of GAS metabolism in re-
sponse to human blood.
Elevated systemic cytokines are thought to contribute
to the pathogenesis of streptococcal toxic shock syn-
drome by activating host complement and coagulation
cascades, increasing plasminogen activator inhibitor
type 1, and reducing fibrinolysis. In extreme cases, ele-
vated cytokines result in hypotension, disseminated in-
travascular coagulation, multiple organ failure, and death
because of lethal shock.45 In concordance, PTSAg activ-
ity is found in acute-phase serum samples from patients
with severe GAS disease, and lack of neutralizing anti-
PTSAg antibodies appears to be a key risk factor for the
development of invasive streptococcal disease.42,46,47
Although regulation of PTSAg production is poorly under-
stood, up-regulation of PTSAg-encoding transcripts dur-
ing blood culture concurs with recent studies indicating
that host factors enhance production of particular PT-
SAgs.48–50 Worldwide resurgence of streptococcal toxic
shock syndrome has been associated with circulation of
novel speA
 strains.51 Our direct measurement of GAS
PTSAg transcripts in human blood supports that SPEG,
SPEJ, SMEZ, but especially SPEA, likely contribute to
GAS-disseminated infections more than previously ap-
preciated. Increased detection of GAS emm1 transcripts
in response to human blood is also notable in light of
recent evidence that soluble M1 protein (released from
GAS surfaces by SPEB) complexes with soluble fibrino-
gen to activate polymorphonuclear lymphocytes, result-
ing in a proinflammatory cascade that promotes vascular
leakage, tissue damage, and streptococcal toxic shock
syndrome development.52
In vitro, we previously observed that CovR plays a
central role in gene regulatory networks by influencing
expression of genes encoding other transcriptional reg-
ulators, including other TCSs, and many GAS genes en-
coding surface and secreted proteins mediating host-
pathogen interactions.9 Although the spectrum of
molecular signals to which GAS is responsive remains
poorly understood, Gryllos and colleagues53 recently re-
ported that CovR-regulated genes are repressed in vitro
under high environmental Mg
2 concentrations. Lower
concentrations of Mg
2 present in mucosal and extracel-
lular body fluids would predict that CovR repressor ac-
tivity is low in these host environments. In keeping with
this postulate, we observed temporary ablation of CovR-
mediated autoregulation and derepression of covRS tran-
scription within 30 minutes in blood. Our data support
temporary CovR-CovS inactivity and enhanced GAS vir-
ulence factor production immediately after human blood
exposure. Surprisingly, transcription of speB (spy2039),
shown in vitro to be CovR-regulated and encoding the
major secreted protease, was decreased throughout the
90-minute time course in both the covR and WT GAS
strains (Supplementary Table 1). This is a significant
observation in the context of reports that this protease
can degrade most of the GAS-secreted proteome, in-
cluding virulence factors such as Emm, SIC, and PT-
SAgs.54 This study revealed that in the complex milieu of
human blood and cells, unknown signals (or regulatory
systems) apparently override CovR regulation of speB.
Importantly, such a prompt reduction of SPEB proteolytic
functionality after blood exposure may be advantageous
to GAS by enhancing (for example) resistance to phago-
cytosis (mediated by intact Emm protein), and disrupting
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host innate defenses through the proliferative and T-cell
V clonal responses of host cells (mediated by full-length
PTSAgs).
Many regulatory genes (n  97) were differentially
expressed throughout time in blood. Some directly mod-
ulate GAS gene expression to elude host defenses,
thereby facilitating persistence and/or dissemination. For
example, transcripts encoding the multiple gene activa-
tor Mga (spy2019) accumulated within 30 minutes and
subsequently declined, whereas transcripts encoding
the TCS Irr-Ihk accumulated within 60 minutes of whole
blood exposure and were sustained. These regulatory
systems play crucial roles in protecting GAS against
immune and innate host defenses.5,55,56 However, addi-
tional transcriptional regulators likely play significant
downstream roles in mediating GAS blood persistence
and adaptation mechanisms.
The data argue that a GAS stress response occurred
during the 90-minute time course and accounts for some
of the observed gene expression changes. For example,
genes functioning in cell envelope biogenesis were sig-
nificantly down-regulated in both strains throughout time
in whole blood. Some degree of cellular shock may be
expected, especially during the first 30 minutes of blood
exposure, owing to GAS harvest by centrifugation, cell
resuspension in iron- and nutrient-limiting whole blood
(after growth in a nutrient-rich, THY medium), increased
osmolality of blood relative to THY broth, and in light of
host inflammatory responses in whole blood. In this con-
text, some temporal changes could be interpreted as
sequential transcriptional remodeling events aimed at
facilitating GAS adaptation and shock recovery on blood
exposure. However, as extracellular physiological fluids
are considered more nutrient-deprived than human
blood, our findings are representative of the kinds of GAS
transcriptional responses that occur during natural infec-
tions, albeit throughout a longer time frame. Transcripts
encoding peptidases, AA-acyl tRNA synthetases, and
protein chaperones were more abundant in the covR
mutant. Interestingly, the CovR-CovS system was dere-
pressed within 30 minutes and then returned to pre-
existing levels; supporting the notion that temporary in-
activation of the CovR repressor allows expression of
GAS gene products that contribute to its cellular adapta-
tion response during mild stress (culture shock) recov-
ery.9 This is supported by a recent report that growth of
GAS, which lacks a sigB ortholog, under mild stress
conditions requires inactivation of CovR to relieve repres-
sion of many GAS genes.57 Consistent with these obser-
vations, GAS viable cell counts after ex vivo culture indi-
cated that approximately two doublings had occurred in
the WT strain and slightly more in the covR mutant, but
the strain count difference did not achieve significance
(data not shown).
Our study has provided the first comprehensive anal-
ysis of how GAS adapts to growth in human blood. On
blood exposure, GAS immediately remodels transcription
through coordinated expression of regulatory, metabolic,
and virulence genes. Transcriptional regulators desig-
nated Mga and Ihk-Irr, and the three-component regula-
tory system called FasBCA (Spy0243-0245) (Figure 3A),
are up-regulated. Increased expression of these regula-
tory systems in turn promotes bacterial fitness and sur-
vival in this host environment by enabling the evasion of
immune and innate host defenses.5,55 Our data also sup-
port the idea that human blood stimuli evoke GAS re-
sponses that facilitate pathogen adaptation in this free
AA-limiting host environment (Figure 3A). Interference
with CovR repressor activity mobilizes metabolic machin-
ery for peptide scavenging, and enhances host cell con-
tact through derepression of capsule and bacterial sur-
face adhesin expression. With time, localized buildup
within the extracellular milieu of nutrient-releasing pro-
teins, such as cytolysins, as well as the proinflammatory
PTSAgs and M protein will disrupt host tissue barriers
and cause host damage that enhances the potential for
bacterial dissemination (Figure 3A). In keeping with mod-
els put forth previously,9,34,58 the CovR-CovS TCS appar-
ently serves to couple as-yet-unidentified environmental
cues to multiple effector outputs, including stress adap-
tation and virulence-associated functions such as cap-
sule, surface adhesins, and secreted proteins (Figure
Figure 3. Time effect and CovR-CovS two-component system involvement
during GAS adaptation to human blood. A: A model for GAS adaptation
throughout time during blood exposure. Numbers at top of figure represent
minutes. On blood entry, GAS immediately remodels transcription to pro-
mote bacterial survival. Successfully persistent, GAS subsequently promotes
host cell contact through surface adhesins and mobilizes metabolic machin-
ery for peptide and AA scavenging in this protein-rich host environment.
Buildup of proteases and proinflammatory molecules secreted into the ex-
tracellular milieu disrupts host tissue barriers and causes host cell damage in
a manner that synergistically enhances bacterial dissemination. B: CovR-CovS
involvement in coordinating fundamental GAS cellular processes. Normally,
phosphoryl group transfer from the membrane-associated histidine kinase
component (CovS) to CovR, its cognate DNA-binding response regulator,
enhances CovR DNA-binding activity. However, human blood exposure
temporarily ablates this transfer event (red hashed line) and CovR-binding
activity is decreased, resulting in derepression of virulence-associated genes
such as capsule, surface adhesins, and secreted proteins. Through direct and
indirect means, GAS adaptively regulates a vast array of genes involved in
cellular metabolism and virulence functions that enable GAS to persist and
replicate successfully in human blood.
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3B). It is unlikely that CovR is directly responsible for all of
the extensive metabolic remodeling we observed.
Rather, we believe that most effects are because of the
downstream impact of CovR derepression on numerous
other regulatory loci (n  97). This interpretation is exem-
plified by a disparate number of down-regulated tran-
scripts (n  532) relative to up-regulated transcripts (n 
270) in the covR versus WT strain comparison through-
out the entire time course. In our simplified model, indi-
rect effects are implied but primarily omitted (Figure 3B).
To summarize, GAS undergoes a rapid, adaptive re-
sponse to host molecular signals in human blood. As a
consequence, cellular metabolism and virulence path-
ways are remodeled, resulting in enhanced survival and
pathogenesis. The CovR-CovS TCS plays a critical role in
directly and indirectly coordinating diverse regulatory
networks in blood and during fulminant GAS infections.
Increased understanding of how GAS and other bacteria
respond to blood could be helpful in developing rapid
diagnostic or therapeutic strategies for disseminated
bacterial infections.
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